{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:27:47Z","timestamp":1773325667150,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018133","name":"VitreoRetinal Surgery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 EY010572"],"award-info":[{"award-number":["P30 EY010572"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006668","name":"Oregon Health and Science University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceutica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ajo.2025.09.052","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:17:31Z","timestamp":1759591051000},"page":"419-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development and Validation of a Commercially Available Two Color Dark Adapted Perimetry to Assess Inherited Retinal Degenerations"],"prefix":"10.1016","volume":"281","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4943-6599","authenticated-orcid":false,"given":"Mark E.","family":"Pennesi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Amato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne","family":"Tschetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin D.","family":"Igelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Birch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lea D.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley A.","family":"Everett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel J.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2025.09.052_bib0001","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.preteyeres.2018.03.005","article-title":"Non-syndromic retinitis pigmentosa","volume":"66","author":"Verbakel","year":"2018","journal-title":"Prog Retin Eye Res"},{"issue":"8","key":"10.1016\/j.ajo.2025.09.052_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/biom14080903","article-title":"Gene therapy for retinitis pigmentosa: current challenges and new progress","volume":"14","author":"Liu","year":"2024","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.ajo.2025.09.052_bib0003","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.18240\/ijo.2024.07.22","article-title":"Retinitis pigmentosa and stem cell therapy","volume":"17","author":"Qi","year":"2024","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.09.052_bib0004","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.preteyeres.2015.06.005","article-title":"pharmacological approaches to retinitis pigmentosa: a laboratory perspective","volume":"48","author":"Guadagni","year":"2015","journal-title":"Prog Retin Eye Res"},{"issue":"11","key":"10.1016\/j.ajo.2025.09.052_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1167\/tvst.9.11.9","article-title":"The RUSH2A study: best-corrected visual acuity, full-field electroretinography amplitudes, and full-field stimulus thresholds at baseline","volume":"9","author":"Birch","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"10.1016\/j.ajo.2025.09.052_bib0006","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/opo.12775","article-title":"Low luminance visual acuity as a clinical measure and clinical trial outcome measure: a scoping review","volume":"41","author":"Wood","year":"2021","journal-title":"Ophthalmic Physiol Opt"},{"issue":"2","key":"10.1016\/j.ajo.2025.09.052_bib0007","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/tvst.10.2.28","article-title":"Low luminance visual acuity and low luminance deficit in choroideremia and RPGR-associated retinitis pigmentosa","volume":"10","author":"Wood","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"10.1016\/j.ajo.2025.09.052_bib0008","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12886-018-0982-0","article-title":"Contrast sensitivity deficits in patients with mutation-proven inherited retinal degenerations","volume":"18","author":"Alahmadi","year":"2018","journal-title":"BMC Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2025.09.052_bib0009","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/bjo.65.12.855","article-title":"Contrast sensitivity in retinitis pigmentosa","volume":"65","author":"Lindberg","year":"1981","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.09.052_bib0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000059627","article-title":"Correlation between contrast sensitivity and visual acuity in retinitis pigmentosa patients","volume":"216","author":"Akeo","year":"2002","journal-title":"Ophthalmologica"},{"issue":"10","key":"10.1016\/j.ajo.2025.09.052_bib0011","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/0042-6989(95)98729-S","article-title":"Visual acuity vs letter contrast sensitivity in retinitis pigmentosa","volume":"35","author":"Alexander","year":"1995","journal-title":"Vision Res"},{"issue":"5","key":"10.1016\/j.ajo.2025.09.052_bib0012","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1755-3768.1981.tb08744.x","article-title":"Contrast sensitivity function in evaluation of visual impairment due to retinitis pigmentosa","volume":"59","author":"Hyvarinen","year":"1981","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"4","key":"10.1016\/j.ajo.2025.09.052_bib0013","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006982-198909040-00009","article-title":"Letter contrast sensitivity in retinitis pigmentosa patients assessed by Regan charts","volume":"9","author":"Spellman","year":"1989","journal-title":"Retina"},{"issue":"6 Suppl","key":"10.1016\/j.ajo.2025.09.052_bib0014","first-page":"S44","article-title":"Contrast sensitivity and color vision in eyes with retinitis pigmentosa and good visual acuity: correlations with SD-OCT findings","volume":"43","author":"Yioti","year":"2012","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"2","key":"10.1016\/j.ajo.2025.09.052_bib0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01203333","article-title":"Correlation between Goldmann perimetry and maximal electroretinogram response in retinitis pigmentosa","volume":"90","author":"Iannaccone","year":"1995","journal-title":"Doc Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2025.09.052_bib0016","first-page":"1693","article-title":"The relationship between visual field size and electroretinogram amplitude in retinitis pigmentosa","volume":"37","author":"Sandberg","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.ajo.2025.09.052_bib0017","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0161-6420(98)96009-2","article-title":"Patterns of visual field progression in patients with retinitis pigmentosa","volume":"105","author":"Grover","year":"1998","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2025.09.052_bib0018","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/bjo.69.5.326","article-title":"A clinical, psychophysical, and electroretinographic survey of patients with autosomal dominant retinitis pigmentosa","volume":"69","author":"Lyness","year":"1985","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.09.052_bib0019","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000055449","article-title":"Progression of visual field loss in patients with retinitis pigmentosa of sporadic and autosomal recessive types","volume":"30","author":"Akeo","year":"1998","journal-title":"Ophthalmic Res"},{"issue":"3","key":"10.1016\/j.ajo.2025.09.052_bib0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1167\/tvst.8.3.36","article-title":"Reliability of semiautomated kinetic perimetry (SKP) and Goldmann kinetic perimetry in children and adults with retinal dystrophies","volume":"8","author":"Barnes","year":"2019","journal-title":"Transl Vis Sci Technol"},{"issue":"7","key":"10.1016\/j.ajo.2025.09.052_bib0021","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3109\/02713683.2015.1079328","article-title":"Quantification of the visual field loss in retinitis pigmentosa using semi-automated kinetic perimetry","volume":"41","author":"Nowomiejska","year":"2016","journal-title":"Curr Eye Res"},{"issue":"2","key":"10.1016\/j.ajo.2025.09.052_bib0022","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1167\/tvst.4.2.14","article-title":"VFMA: topographic analysis of sensitivity data from full-field static perimetry","volume":"4","author":"Weleber","year":"2015","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ajo.2025.09.052_bib0023","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajo.2023.02.002","article-title":"Static perimetry in the rate of progression in USH2A-related retinal degeneration (RUSH2A) study: assessment through 2 years","volume":"250","author":"Duncan","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.09.052_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.101000","article-title":"Full-field stimulus testing: role in the clinic and as an outcome measure in clinical trials of severe childhood retinal disease","volume":"87","author":"Roman","year":"2022","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"10.1016\/j.ajo.2025.09.052_bib0025","article-title":"Detailed evaluation of chromatic pupillometry and full-field stimulus testing to assess ultralow vision in retinitis pigmentosa","volume":"3","author":"Yamamoto","year":"2023","journal-title":"Ophthalmol Sci"},{"issue":"5","key":"10.1016\/j.ajo.2025.09.052_bib0026","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1017\/S0952523800175029","article-title":"Rod and cone visual cycle consequences of a null mutation in the 11-cis-retinol dehydrogenase gene in man","volume":"17","author":"Cideciyan","year":"2000","journal-title":"Vis Neurosci"},{"issue":"9","key":"10.1016\/j.ajo.2025.09.052_bib0027","first-page":"1786","article-title":"Rod plateaux during dark adaptation in Sorsby\u2019s fundus dystrophy and vitamin A deficiency","volume":"38","author":"Cideciyan","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2025.09.052_bib0028","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00143336","article-title":"Two forms of autosomal dominant primary retinitis pigmentosa","volume":"51","author":"Massof","year":"1981","journal-title":"Doc Ophthalmol"},{"issue":"4 Part 2","key":"10.1016\/j.ajo.2025.09.052_bib0029","first-page":"253","article-title":"Rod and cone vision in retinitis pigmentosa","volume":"42","author":"Wald","year":"1956","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.09.052_bib0030","first-page":"263","article-title":"Rod sensitivity relative to cone sensitivity in retinitis pigmentosa","volume":"18","author":"Massof","year":"1979","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ajo.2025.09.052_bib0031","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/bjo.67.7.431","article-title":"An automated statis perimeter\/adaptometer using light emitting diodes","volume":"67","author":"Ernst","year":"1983","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.09.052_bib0032","first-page":"954","article-title":"The relationship between rod perimetric thresholds and full-field rod ERGs in retinitis pigmentosa","volume":"28","author":"Birch","year":"1987","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ajo.2025.09.052_bib0033","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/S0161-6420(86)33522-X","article-title":"Automated light- and dark-adapted perimetry for evaluating retinitis pigmentosa","volume":"93","author":"Jacobson","year":"1986","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2025.09.052_bib0034","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.exer.2004.09.008","article-title":"Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures","volume":"80","author":"Roman","year":"2005","journal-title":"Exp Eye Res"},{"issue":"7","key":"10.1016\/j.ajo.2025.09.052_bib0035","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1167\/iovs.16-19302","article-title":"Automated light- and dark-adapted perimetry for evaluating retinitis pigmentosa: filling a need to accommodate multicenter clinical trials","volume":"57","author":"McGuigan","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2025.09.052_bib0036","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1167\/tvst.12.4.17","article-title":"Improved rod sensitivity as assessed by two-color dark-adapted perimetry in patients with RPE65-related retinopathy treated with voretigene neparvovec-rzyl","volume":"12","author":"Ku","year":"2023","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"10.1016\/j.ajo.2025.09.052_bib0037","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/tvst.5.3.10","article-title":"Selective automated perimetry under photopic, mesopic, and scotopic conditions: detection mechanisms and testing strategies","volume":"5","author":"Simunovic","year":"2016","journal-title":"Transl Vis Sci Technol"},{"issue":"4","key":"10.1016\/j.ajo.2025.09.052_bib0038","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1167\/tvst.6.4.15","article-title":"Dark-adapted chromatic perimetry for measuring rod visual fields in patients with retinitis pigmentosa","volume":"6","author":"Bennett","year":"2017","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"10.1016\/j.ajo.2025.09.052_bib0039","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1167\/iovs.63.3.17","article-title":"The RUSH2A study: dark-adapted visual fields in patients with retinal degeneration associated with biallelic variants in the USH2A gene","volume":"63","author":"Birch","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ajo.2025.09.052_bib0040","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3928\/23258160-20221118-03","article-title":"Two-color dark-adapted perimetry implemented with a commercially available perimeter to characterize rod-pathway sensitivity","volume":"53","author":"Igelman","year":"2022","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"1","key":"10.1016\/j.ajo.2025.09.052_bib0041","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/s41467-017-01816-6","article-title":"Rods progressively escape saturation to drive visual responses in daylight conditions","volume":"8","author":"Tikidji-Hamburyan","year":"2017","journal-title":"Nat Commun"},{"issue":"14","key":"10.1016\/j.ajo.2025.09.052_bib0042","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/tvst.10.14.18","article-title":"Effect of pharmacological pupil dilation on dark-adapted perimetric sensitivity in healthy subjects using an Octopus 900 perimeter","volume":"10","author":"Igelman","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"10.1016\/j.ajo.2025.09.052_bib0043","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11517-016-1485-x","article-title":"Comparison of nonparametric methods for static visual field interpolation","volume":"55","author":"Smith","year":"2017","journal-title":"Med Biol Eng Comput"},{"issue":"7","key":"10.1016\/j.ajo.2025.09.052_bib0044","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1167\/tvst.10.7.12","article-title":"Microperimetry hill of vision and volumetric measures of retinal sensitivity","volume":"10","author":"Josan","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"8476","key":"10.1016\/j.ajo.2025.09.052_bib0045","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ajo.2025.09.052_bib0046","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1167\/iovs.18-25473","article-title":"Regional variations and intra-\/intersession repeatability for scotopic sensitivity in normal controls and patients with inherited retinal degenerations","volume":"60","author":"Bennett","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2025.09.052_bib0047","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/IAE.0000000000002808","article-title":"Clinical characteristics and natural history of rho-associated retinitis pigmentosa: a long-term follow-up study","volume":"41","author":"Nguyen","year":"2021","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.ajo.2025.09.052_bib0048","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1167\/iovs.07-1110","article-title":"Retinal laminar architecture in human retinitis pigmentosa caused by Rhodopsin gene mutations","volume":"49","author":"Aleman","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"19","key":"10.1016\/j.ajo.2025.09.052_bib0049","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1074\/jbc.RA117.001574","article-title":"Guanylate cyclase-activating protein 2 contributes to phototransduction and light adaptation in mouse cone photoreceptors","volume":"293","author":"Vinberg","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajo.2025.09.052_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100619","article-title":"Molecular properties of human guanylate cyclase-activating protein 2 (GCAP2) and its retinal dystrophy-associated variant G157R","volume":"296","author":"Avesani","year":"2021","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.ajo.2025.09.052_bib0051","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0896-6273(94)90355-7","article-title":"Molecular cloning and characterization of retinal photoreceptor guanylyl cyclase-activating protein","volume":"13","author":"Palczewski","year":"1994","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.ajo.2025.09.052_bib0052","doi-asserted-by":"crossref","DOI":"10.3390\/genes8100256","article-title":"The genetic basis of pericentral retinitis pigmentosa-a form of mild retinitis pigmentosa","volume":"8","author":"Comander","year":"2017","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.ajo.2025.09.052_bib0053","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010086","article-title":"Clinical and genetic analysis of a european cohort with pericentral retinitis pigmentosa","volume":"21","author":"Karali","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajo.2025.09.052_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100898","article-title":"The X-linked retinopathies: physiological insights, pathogenic mechanisms, phenotypic features and novel therapies","volume":"82","author":"De Silva","year":"2021","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"10.1016\/j.ajo.2025.09.052_bib0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/tvst.13.2.13","article-title":"Chorioretinal atrophy growth after voretigene neparvovec retinotopically is connected to retinal functional rescue","volume":"13","author":"Stingl","year":"2024","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"10.1016\/j.ajo.2025.09.052_bib0056","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0161-6420(99)90064-7","article-title":"Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy","volume":"106","author":"Birch","year":"1999","journal-title":"Ophthalmology"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425005264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425005264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:23:31Z","timestamp":1773275011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939425005264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":56,"alternative-id":["S0002939425005264"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2025.09.052","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and Validation of a Commercially Available Two Color Dark Adapted Perimetry to Assess Inherited Retinal Degenerations","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2025.09.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}